Fiji vs Maldives: Death rate from pneumonia
Fiji
22.73 deaths per 100,000 people
in 2021
Maldives
22.14 deaths per 100,000 people
in 2021
Fiji rank
115th
Maldives rank
118th
Death rate from pneumonia over time
- Fiji
- Maldives
How they compare
Fiji currently reports 22.73 deaths per 100,000 people against 22.14 deaths per 100,000 people in Maldives, a difference of 0.59 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Fiji ahead.
Fiji ranks 115th and Maldives ranks 118th of 194 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Maldives in 1.
Head to head by decade
| Decade | Fiji | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.27 deaths per 100,000 people | 18.82 deaths per 100,000 people | 6.45 deaths per 100,000 people | Fiji |
| 2010s | 25.06 deaths per 100,000 people | 14.46 deaths per 100,000 people | 10.6 deaths per 100,000 people | Fiji |
| 2020s | 23.78 deaths per 100,000 people | 24.2 deaths per 100,000 people | 0.415 deaths per 100,000 people | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from pneumonia, Fiji or Maldives?
- Fiji, at 22.73 deaths per 100,000 people against 22.14 deaths per 100,000 people in Maldives as of 2021.
- What is the difference in death rate from pneumonia between Fiji and Maldives?
- 0.59 deaths per 100,000 people, with Fiji ahead.
- How many years of comparable data are there for Fiji and Maldives?
- 22 years are reported by both, from 2000 to 2021.
- How do Fiji and Maldives rank globally for death rate from pneumonia?
- Fiji ranks 115th and Maldives ranks 118th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from pneumonia. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from lower respiratory infections in both sexes, per 100,000 people.